Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)
Clinical trial NCT01374425 · COMPLETED
Trial details
- NCT number
- NCT01374425
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-08-01
- Primary completion
- 2015-05-01
- Enrollment
- 376
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.